NEW YORK STATE RHEUMATOLOGY SOCIETY INC (EIN 201831400) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

HOWARD BLUMSTEIN

Phone

6316567198

Tax Period

2025-01-01 to 2025-12-31

NEW YORK STATE RHEUMATOLOGY SOCIETY INC, founded in 2004, is a small nonprofit in the Diseases & Disorders sector that reported $462K in total revenue in fiscal year 2025. Expenses of $444K left a modest 4% surplus.

Mission

EDUCATION & ADVOCACY OF ARTHRITIS HEALTHCARE

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $462,095

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $462,095

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $444,476

Other Expenses $444,476

TOTAL EXPENSES $444,476

Year-over-Year Comparison

	2025	2024	Change
Revenue	$462,095	$431,860	+0.1%
Expenses	$444,476	$398,733	+0.1%
Net Income	$17,619	$33,127	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,500

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HOWARD BLUMSTEIN	OFFICER	0.00	Officer	$0	$0	$0
JOSEPH GRISANTI	OFFICER	0.00	Officer	$0	$0	$0
MARGRIT WIESENDANGER	OFFICER	1.00	Officer	$1,500	$0	$1,500
MAX HAMBURGER	TREASURER	0.00	Officer	$0	$0	$0
KHO HUTU NGO	PRESIDENT	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$462,095	$444,476	$363,674	$17,619
2024	$431,860	$398,733	$346,055	$33,127
2023	$396,970	$374,826	$312,928	$22,144
2022	$308,550	$363,272	$290,784	$-54,722
2021	$269,950	$223,302	$345,506	$46,648
2020	$109,300	$111,909	$298,858	$-2,609
2019	$324,150	$294,123	$301,467	$30,027
2018	$420,991	$264,024	$271,440	$156,967

NEW YORK STATE RHEUMATOLOGY SOCIETY INC